Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy

Clinical trial NCT02210819 · COMPLETED

Trial details

NCT number: NCT02210819
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)

Start date: 2014-06-27
Primary completion: 2016-11-03
Enrollment: 1987

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.